Morgan Stanley’s IO Biotech IOBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $909K | Sell |
653,678
-135,783
| -17% | -$189K | ﹤0.01% | 5150 |
|
|
2025
Q1 | $861K | Sell |
789,461
-69,714
| -8% | -$76K | ﹤0.01% | 5075 |
|
|
2024
Q4 | $790K | Sell |
859,175
-1,342,910
| -61% | -$1.24M | ﹤0.01% | 5208 |
|
|
2024
Q3 | $2.31M | Buy |
2,202,085
+229,742
| +12% | +$241K | ﹤0.01% | 4543 |
|
|
2024
Q2 | $2.31M | Sell |
1,972,343
-224,891
| -10% | -$263K | ﹤0.01% | 4467 |
|
|
2024
Q1 | $3.8M | Sell |
2,197,234
-2,366,130
| -52% | -$4.09M | ﹤0.01% | 4135 |
|
|
2023
Q4 | $8.58M | Buy |
4,563,364
+4,494,551
| +6,532% | +$8.45M | ﹤0.01% | 4037 |
|
|
2023
Q3 | $97K | Sell |
68,813
-135
| -0.2% | -$190 | ﹤0.01% | 5906 |
|
|
2023
Q2 | $135K | Buy |
68,948
+25,753
| +60% | +$50.3K | ﹤0.01% | 5812 |
|
|
2023
Q1 | $81K | Buy |
43,195
+14,135
| +49% | +$26.5K | ﹤0.01% | 6096 |
|
|
2022
Q4 | $66.8K | Buy |
29,060
+7,000
| +32% | +$16.1K | ﹤0.01% | 6159 |
|
|
2022
Q3 | $60K | Sell |
22,060
-2,049
| -8% | -$5.57K | ﹤0.01% | 6326 |
|
|
2022
Q2 | $113K | Buy |
24,109
+7,622
| +46% | +$35.7K | ﹤0.01% | 6210 |
|
|
2022
Q1 | $87K | Buy |
16,487
+7,529
| +84% | +$39.7K | ﹤0.01% | 6396 |
|
|
2021
Q4 | $57K | Buy |
+8,958
| New | +$57K | ﹤0.01% | 6749 |
|